Therapeutic formulations for the treatment of beta-amyloid related diseases
A technology of amyloid, therapeutic agent, applied in nervous system diseases, peptide/protein components, medical preparations containing active ingredients, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific example
[0309] Specific examples of peptides described in WO 02 / 096937 A2 that can be used in the present invention include the following:
[0310] Aβ(1-42, all-D)DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,
[0311] Aβ(1-40, all-D)DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV,
[0312] Aβ(1-35, all-D)DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLM,
[0313] Aβ(1-28, all-D)DAEFRHDSGYEVHHQKLVFFAEDVGSNK,
[0314] Aβ(1-7, all-D)DAEFRHD,
[0315] Aβ(10-16, all-D)YEVHHQK,
[0316] Aβ(16-21, all-D)KLVFFA,
[0317] Aβ(10-21, all-D)YEVHHQKLVFFA,
[0318] Aβ(13-21, all-D)HHQKLVFFA,
[0319] Aβ(36-42, all-D)VGGVVIA, and
[0320] Lys-Ile-Val-Phe-Phe-Ala (all-D); Lys-Lys-Leu-Val-Phe-Phe-Ala (all-D);
[0321] Lys-Phe-Val-Phe-Phe-Ala (all-D); Ala-Phe-Phe-Val-Leu-Lys (all-D); Lys-Leu-Val-Phe (all-D);
[0322] Lys-Ala-Val-Phe-Phe-Ala (all-D); Lys-Leu-Val-Phe-Phe (all-D); Lys-Leu-Val-Phe-Phe-Ala-NH 2 (All-D); Lys-Ile-Val-Phe-Phe-Ala-NH 2 (All-D); Lys-Leu-Val-Phe-Phe-Ala-NH 2 (full-D);
[0323] Lys-Phe-Val-...
Embodiment
[0653] Binding and Antigen Fibril Formation Tests
[0654] Test compounds were purchased from commercial sources or synthesized or screened by mass spectrometry ("MS") analysis. MS analysis gives data on the ability of the compound to bind amyloid.
[0655] In mass spectrometry ("MS") analysis, samples were prepared as aqueous solutions containing 20% ethanol, 200 [mu]M test compound and 20 [mu]M dissolved A[beta]40. The pH of each sample was adjusted to 7.4 (±0.2) by adding 0.1% aqueous sodium hydroxide. The solution was then analyzed by electrospray ionization mass spectrometry using a Waters ZQ 4000 mass spectrometer. Samples were introduced by direct infusion at a flow rate of 25 μL / min within 2 hours of sample preparation. The source temperature was maintained at 70°C and the pore voltage was 20V for all analyses. Data were processed using Masslynx 3.5 software. The MS test gives data on the ability of the compound to bind soluble A[beta], while the ThT, EM and CD ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com